ID   HR89
AC   CVCL_E3ZH
RX   Patent=EP0368466B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9759.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16412; Lipopolysaccharide.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6741 ! WI-L2-729HF2
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   Patent=EP0368466B1;
RA   Bubbers J.E., Castaldi D.L., Mankarious S., Hooper J.A., Alpern M.;
RT   "Compositions and methods for the treatment and prevention of
RT   Gram-negative bacterial infections.";
RL   Patent number EP0368466B1, 29-Nov-1995.
//